InvenireX
PrivateLast Round
Seed
Nov 18, 2025
Total Funding Raised
$3.27M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
InvenireX is a biotechnology company that develops an ultra-sensitive, real-time nucleic acid detection platform powered by DNA nanotechnology and artificial intelligence for use in molecular diagnostics and life sciences research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InvenireX Comparables
Compare InvenireX with similar companies based on industry and business-model similarity.
InvenireX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 18, 2025 | ||||
| Seed | Mar 18, 2024 |
InvenireX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Seed |
| XTX Ventures | Seed |
| DSW Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 18, 2025
$2.6M raised led by DSW Ventures.
- Nov 12, 2025
Grew 100% QoQ from 5 to 10 employees.
InvenireX Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about InvenireX's valuation, stock price, and market status.